施洁国际，全球领先的合同灭菌、γ技术和医用同位素提供商，今天宣布扩大他们位于德克萨斯的沃思堡工厂的辐照能力，通过添加一个新的伽玛辐照装置，产能将增加30%。扩张将在2017年第二季度完成。

DEERFIELD, Ill.--(BUSINESS WIRE)--Sterigenics International, the leading global provider of contract sterilization, gamma technologies and medical isotopes, today announced expansion at their Forth Worth, Texas location, with the addition of a new gamma cell that will increase capacity by 30%. Expansion will be complete by Q2 2017.

“在过去的一年里，我们投入超过8000万美元的资本来支持客户的增长战略,”施洁的首席执行官Michael Mulhern说，“除了沃思堡工厂的扩张，我们还扩大了施杰位于阿肯色州西孟菲斯工厂达三倍的杀菌能力；显著扩大了我们位于伊利诺斯州格尼市的辐照设施，通过收购位于拉丁美洲主要灭菌公司Companhia Brasileira de Esterilização(CBE)增加了我们的全球服务能力。”

“We have committed more than $80 million in capital investments in the past year to support our customers’ growth strategies,” said Michael Mulhern, CEO of Sterigenics International. “In addition to our Fort Worth expansion, we tripled sterilization capacity at the Sterigenics West Memphis, Arkansas location; significantly expanded our Gurnee, Illinois irradiation facility and increased our global service capabilities with the acquisition of leading Latin American sterilization firm Companhia Brasileira de Esterilização (CBE).”

“沃斯堡扩张是地区对Sterigenics辐照服务需求增加的直接结果，”施洁国际LLC总裁Philip Macnabb说，”我们在德克萨斯州增加伽马处理能力每年高达500万立方英尺，通过一个产品重叠系统，这将提供更大的剂量范围和各种不同密度的产品处理能力。”

“The Fort Worth expansion is the direct result of increased regional demand for Sterigenics irradiation services,” said Philip Macnabb, President of Sterigenics International LLC. “We are adding gamma processing capacity of up to 5 million cubic feet per year in Texas, with a product overlap system which will provide the capability to process numerous dose ranges and a wide variety of densities.”

于1984年开业，Sterigenics沃思堡工厂提供常规γ，GammaStat®快速处理，工艺验证和SteriPro®实验室测试。

Opened in 1984, Sterigenics Fort Worth provides routine gamma, GammaStat® rapid processing, process validation and SteriPro® laboratory testing.

关于施杰国际 About Sterigenics International LLC

施洁国际有限责任公司，连同其附属公司，是全球外包合同灭菌服务、γ技术和医用同位素领导者，全球唯一的垂直整合的灭菌公司。运行在美洲、欧洲和亚洲的12个国家超过47个工厂。Sterigenics为医疗设备，制药,食品安全，和高性能材料产业提供合同灭菌和电离服务。通过其SteriPro®实验室服务，Sterigenics提供微生物和分析测试和咨询，以协助客户开发和维护医疗器械，织物/植入产品，药品和生物制品领域的灭菌解决方案。附属公司Nordion将Sterigenics定位为全球最大的用于伽马消毒过程以及用于诊断和治疗各种疾病和癌症的医用同位素钴-60的提供者。施洁国际有限责任公司及其子公司服务全球超过2500家客户，由私人股本公司Warburg Pincus 和GTCR所拥有。

Sterigenics International LLC, along with its affiliates, is a global leader in outsourced contract sterilization services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 47 facilities in 12 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. Through its SteriPro® Labs service, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Affiliate Nordion positions Sterigenics as the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics International LLC and its affiliates serve more than 2,500 customers around the world and is owned by private equity firms Warburg Pincus and GTCR.

Contacts

John Steven Vita Communications
John Vita, 847-853-8283
John.Vita@jsvcom.com